Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Systematic Review
65%
Adverse Drug Reaction
51%
Potentially Inappropriate Medication
46%
Qualitative Study
37%
Nursing Home
34%
Primary Medical Care
29%
Polypharmacy
28%
Practice Guideline
27%
General Practitioner
25%
Health Care Personnel
24%
Older Person
24%
Teaching Hospital
20%
Deprescribing
19%
Hospitalized Older Adults
18%
Drug Therapy
17%
Antiinfective Agent
16%
Multiple Chronic Conditions
16%
Antimicrobial Stewardship
15%
Meta Analysis
15%
Adherence
15%
Long Term Care
14%
Benzodiazepine
14%
Heart Infarction
14%
Protocol Compliance
14%
Hospital Setting
13%
Cost Effectiveness Analysis
13%
General Practice
13%
Qualitative Research
12%
Hospital Physician
12%
Benzodiazepine Derivative
12%
Treatment Center
12%
Gerontology
11%
Side Effect
11%
Medline
11%
Decision Support System
11%
Point of Care Testing
11%
Content Analysis
9%
Mindfulness
9%
Patient Safety
9%
Psychotropic Agent
9%
Cannabis
9%
Health Care Cost
9%
CINAHL
9%
Diseases
9%
Inappropriate Prescribing
9%
Clinical Outcome
9%
University Hospital
9%
Quality of Life
8%
Malignant Neoplasm
8%
Anticoagulation
8%
Decision-Making
8%
Medication Compliance
8%
Hospital Pharmacist
7%
Cost Benefit Analysis
7%
Adverse Event
7%
Pharmaceutical Care
7%
Confidence Interval
7%
Secondary Prevention
7%
Medication Therapy Management
6%
Prevalence
6%
Self Evaluation
6%
Clinical Practice
6%
Study Participant
6%
Clinical Pharmacist
6%
Randomization
6%
Ward
6%
Anamnesis
6%
Self Care
6%
International Normalized Ratio
6%
Low Density Lipoprotein Cholesterol
6%
Health Care Policy
5%
Life Expectancy
5%
Frailty
5%
Care Pathway
5%
Embase
5%
Prescription Drug
5%
Cohort Analysis
5%
Chi Square Test
5%
Healthcare System
5%
Treatment Outcome
5%
Thematic Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
100%
Randomized Controlled Trial
77%
Polypharmacy
66%
Prevalence
57%
Pharmacotherapy
50%
Beers Criteria
39%
Multiple Chronic Conditions
34%
Diseases
25%
Community Pharmacy
19%
Warfarin
17%
Antibiotics
16%
Congestive Heart Failure
15%
Subclinical Hypothyroidism
15%
Side Effect
14%
Levothyroxine
13%
Clinical Pharmacy
13%
Placebo
13%
Antiinfective Agent
12%
Thyroid Hormone
12%
Comorbidity
11%
Anticoagulation Therapy
11%
Pharmaceutical Care
11%
Cross Sectional Study
11%
Observational Study
10%
2,5-Dimethoxy-4-iodoamphetamine
9%
Antipsychotic
9%
Cannabis
9%
Cholinergic Receptor Blocking Agent
9%
Adverse Event
8%
Amoxicillin
8%
Base
8%
Adverse Outcome
7%
Low Density Lipoprotein Cholesterol
7%
All Cause Mortality
7%
Clinical Trial
6%
Thyrotropin
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Cohort Study
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Proton Pump Inhibitor
6%
Life Expectancy
6%
Frailty
6%
Beta Adrenergic Receptor Blocking Agent
6%
Drug Interaction
6%
Anticoagulant Agent
5%
Pharmacokinetic
5%
Medical History
5%
Dyslipidemia
5%
Medicine and Dentistry
Adverse Drug Reaction
57%
Randomized Controlled Trial
46%
Potentially Inappropriate Medication
43%
Polypharmacy
38%
Drug Therapy
33%
Multiple Chronic Conditions
31%
Systematic Review
25%
Health Care Cost
21%
Primary Health Care
19%
General Practitioner
15%
Inappropriate Prescribing
15%
Mixed Methods
14%
Arm
13%
Quality of Life
13%
Anticoagulation
13%
Prevalence
12%
Cost-Effectiveness Analysis
11%
Medicine
11%
Decision Making
11%
Subclinical Hypothyroidism
10%
Health Care Personnel
9%
Controlled Clinical Trial
9%
Self-Diagnosis
9%
Meta-Analysis
9%
Safety Culture
9%
Health System
9%
Antipsychotic
9%
General Medicine
9%
Diseases
9%
Academic Detailing
9%
Maturity Onset Diabetes of the Young
9%
Nursing Home
9%
Levothyroxine
8%
Geriatrics
8%
Antibiotics
8%
Public Health
8%
Placebo
8%
All Cause Mortality
7%
Cross Sectional Study
7%
Oral
7%
Prescription Drug
7%
Anticoagulant Therapy
7%
Thyroid Hormone
7%
Primary Outcome
7%
Quality Adjusted Life Year
6%
Clinical Decision Support System
6%
Outpatient
6%
Behavioral Change
6%
Clinical Trial
6%
Base
5%
Hormone Substitution
5%
Intervention Trial
5%
Patient with Diabetes
5%
Patient Safety
5%
Adverse Event
5%